-
In a double-blind, randomized clinical trial, amoxicillin therapy did not improve outcomes in patients with clinically diagnosed acute rhinosinusitis.
-
In a cross-sectional sample of postmenopausal women not using hormonal therapy, higher serum levels of estrogen were associated with improved semantic memory and verbal episodic memory abilities.
-
The comments below are in response to the article "Early Referral of the Chronic Kidney Disease Patient is Good Practice," by Rahul Gupta, MD, MPH, FACP, which appeared in the Jan. 29, 2012, issue. The comments from two of our editorial board members represent somewhat differing perspectives on the role of the primary care clinician in the management of chronic kidney disease. Obviously there is great opportunity for improvement in this area and those of us in primary care are in a unique position to optimize outcomes. Stephen Brunton, MD, Editor
-
This study confirms that cefpodoxime should only be prescribed for the treatment of cystitis when more effective recommended antibiotics cannot be used.
-
Actinic keratoses (AK) is biologically in situ squamous cell carcinoma, with the potential to become invasive in a minority of cases.
-
Scenario: The 12-lead ECG shown above was obtained from a 72-year-old woman seen in the emergency department (ED) with new-onset chest discomfort. No prior ECGs were available for comparison. The tracing was interpreted as "showing no acute changes." Do you agree? What else do you see?
-
Elderly patients are often prescribed analgesics after ambulatory and short-stay surgery which may lead to their long-term use.
-
Treatment of dyslipidemia with statins produces consistent, durable lowering of low-density lipoprotein cholesterol (LDL-C), which is associated with substantial reductions in myocardial infarction and stroke.
-
Short (< 7 hours/night) sleep duration is associated with increased BMI and increased genetic influences on BMI. Longer sleep duration may reduce genetic influences on body weight.
-
A completely synthetic, once-monthly, erythropoiesis-stimulating agent has been approved for the treatment of anemia in dialysis patients.
